Results 121 to 130 of about 4,511 (199)

Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors. [PDF]

Front Immunol
Ogawa H, Ekawa T, Mizote Y, Akazawa T, Tahara H.   +4 more
europepmc   +1 more source

The role of alternative splicing in gastric cancer. [PDF]

Biol Direct
Huang Q, Ke J, Shen X, Xu Y, Sun S, Huang C.   +5 more
europepmc   +1 more source

Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects. [PDF]

Front Immunol
Zhao H, Zhang S, Wang F, Yu P, Li J, Jia L, He P, Liu R, Zhang J, Wang K, Han R, Huangfu H.   +11 more
europepmc   +1 more source

Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts. [PDF]

Mol Cancer Ther
Lundgren Mortensen AC, Berglund H, Jha P, Stenman A, Selvaraju RK, Lundqvist H, Hofström C, Persson H, Juhlin CC, Zedenius J, Frejd FY, Nestor M.   +11 more
europepmc   +1 more source

Update on the Association of CD44 Expression with Esophageal Squamous Cell Carcinoma Invasion. [PDF]

Rep Biochem Mol Biol
Fadaee A, Kamal Kheder R, Otaiwe Alrawi RS, Nojoumi M, Esmaeili SA, Mansouri A.   +5 more
europepmc   +1 more source

CD44v6-mediated regulation of gastric cancer stem cells: a potential therapeutic target. [PDF]

Clin Exp Med
Chen H, Ling R, Lai J, Liu Z, Wang Z, Yang H, Kong Y.   +6 more
europepmc   +1 more source

Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants. [PDF]

Int J Mol Sci
Mostaq MS, Amin MN, Raphael A, Asbury C, Gupta A, Gu X, Han X, Sekulic D, Michalak P, Kang L, Liu YY.   +10 more
europepmc   +1 more source

Stroma-Dominant Colorectal Cancer Harbors CAF-Rich Spatial Architecture and EMT-Associated Cancer Cell Plasticity Detectable After Dissemination. [PDF]

Biomolecules
Kitagawa S, Mimura N, Kambara H, Hori M, Yamanishi E, Ogo A, Shiomi T, Yoshimatsu K, Ueno T, Yano S.   +9 more
europepmc   +1 more source

Precision medicine with car cells in acute myeloid leukemia: where are we? [PDF]

Front Immunol
Zanetti LC, Tomaz V, de Souza IF, Campregher PV, Hamerschlak N, Kerbauy LN.   +5 more
europepmc   +1 more source

CD44 variant exons induce chemoresistance by modulating cell death pathways. [PDF]

Front Cell Dev Biol
Yanova M, Stepanova E, Maltseva D, Tonevitsky A.   +3 more
europepmc   +1 more source